Aerovate Therapeutics is a biotechnology company focused on developing drugs that meaningfully improve the lives of patients. Founded in 2019, Aerovate Therapeutics is backed by investors that include Cormorant Asset Management, Atlas Venture, Sofinnova Investments, Surveyor Capital, and OUP (Osage University Partners) and is headquartered in Boston.